These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34799097)

  • 1. From the Group to the Individual in Schizophrenia Spectrum Disorders: Biomarkers of Social Cognitive Impairments and Therapeutic Translation.
    Oliver LD; Hawco C; Viviano JD; Voineskos AN
    Biol Psychiatry; 2022 Apr; 91(8):699-708. PubMed ID: 34799097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants.
    Oliver LD; Hawco C; Homan P; Lee J; Green MF; Gold JM; DeRosse P; Argyelan M; Malhotra AK; Buchanan RW; Voineskos AN;
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Dec; 6(12):1202-1214. PubMed ID: 33579663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects.
    Viviano JD; Buchanan RW; Calarco N; Gold JM; Foussias G; Bhagwat N; Stefanik L; Hawco C; DeRosse P; Argyelan M; Turner J; Chavez S; Kochunov P; Kingsley P; Zhou X; Malhotra AK; Voineskos AN;
    Biol Psychiatry; 2018 Nov; 84(9):665-674. PubMed ID: 29779671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder: A Systematic Review, Meta-analysis, and Meta-regression.
    Oliver LD; Moxon-Emre I; Lai MC; Grennan L; Voineskos AN; Ameis SH
    JAMA Psychiatry; 2021 Mar; 78(3):281-292. PubMed ID: 33291141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia.
    Eack SM; Wojtalik JA; Keshavan MS; Minshew NJ
    Schizophr Res; 2017 May; 183():102-109. PubMed ID: 28291690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome.
    Oliver LD; Haltigan JD; Gold JM; Foussias G; DeRosse P; Buchanan RW; Malhotra AK; Voineskos AN;
    Schizophr Bull; 2019 Apr; 45(3):629-638. PubMed ID: 30107517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Repetitive Transcranial Magnetic Stimulation on Working Memory Performance and Brain Structure in People With Schizophrenia Spectrum Disorders: A Double-Blind, Randomized, Sham-Controlled Trial.
    Voineskos AN; Blumberger DM; Schifani C; Hawco C; Dickie EW; Rajji TK; Mulsant BH; Foussias G; Wang W; Daskalakis ZJ
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Apr; 6(4):449-458. PubMed ID: 33551284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain connectivity and auditory hallucinations: In search of novel noninvasive brain stimulation therapeutic approaches for schizophrenia.
    Thomas F; Moulier V; Valéro-Cabré A; Januel D
    Rev Neurol (Paris); 2016 Nov; 172(11):653-679. PubMed ID: 27742234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions.
    Voineskos AN; Hawco C; Neufeld NH; Turner JA; Ameis SH; Anticevic A; Buchanan RW; Cadenhead K; Dazzan P; Dickie EW; Gallucci J; Lahti AC; Malhotra AK; Öngür D; Lencz T; Sarpal DK; Oliver LD
    World Psychiatry; 2024 Feb; 23(1):26-51. PubMed ID: 38214624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging-Guided and Navigated Individualized Repetitive Transcranial Magnetic Stimulation for Cognitive Impairment in Schizophrenia.
    Wu XS; Yan TC; Wang XY; Cao Y; Liu XF; Fu YF; Wu L; Jin YC; Yin H; Cui LB
    Neurosci Bull; 2021 Sep; 37(9):1365-1369. PubMed ID: 34145549
    [No Abstract]   [Full Text] [Related]  

  • 11. Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia.
    Adraoui FW; Douw L; Martens GJM; Maas DA
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional network connectivity impairments and core cognitive deficits in schizophrenia.
    Adhikari BM; Hong LE; Sampath H; Chiappelli J; Jahanshad N; Thompson PM; Rowland LM; Calhoun VD; Du X; Chen S; Kochunov P
    Hum Brain Mapp; 2019 Nov; 40(16):4593-4605. PubMed ID: 31313441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational and Therapeutic Applications of Transcranial Magnetic Stimulation in Schizophrenia.
    Mehta UM; Naik SS; Thanki MV; Thirthalli J
    Curr Psychiatry Rep; 2019 Aug; 21(9):89. PubMed ID: 31410587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.
    Hasan A; Strube W; Palm U; Wobrock T
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S95-S109. PubMed ID: 27460623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial.
    Thomas F; Bouaziz N; Gallea C; Schenin-King Andrianisaina P; Durand F; Bolloré O; Benadhira R; Isaac C; Braha-Zeitoun S; Moulier V; Valero-Cabré A; Januel D
    Trials; 2019 Apr; 20(1):229. PubMed ID: 31014369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Social cognition in schizophrenia and autism spectrum disorder: Points of convergence and functional differences].
    Le Gall E; Iakimova G
    Encephale; 2018 Dec; 44(6):523-537. PubMed ID: 30122298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcranial electrical brain stimulation methods for treatment of negative symptoms in schizophrenia].
    Haller N; Hasan A; Padberg F; Strube W; da Costa Lane Valiengo L; Brunoni AR; Brunelin J; Palm U
    Nervenarzt; 2022 Jan; 93(1):41-50. PubMed ID: 33492411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic Connectivity Patterns of Task-Defined Brain Networks Allow Individual Prediction of Cognitive Symptom Dimension of Schizophrenia and Are Linked to Molecular Architecture.
    Chen J; Müller VI; Dukart J; Hoffstaedter F; Baker JT; Holmes AJ; Vatansever D; Nickl-Jockschat T; Liu X; Derntl B; Kogler L; Jardri R; Gruber O; Aleman A; Sommer IE; Eickhoff SB; Patil KR
    Biol Psychiatry; 2021 Feb; 89(3):308-319. PubMed ID: 33357631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
    Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
    BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.